From: David Dove [daviddove1@rcn.com]
Sent: Tuesday, June 18, 2002 12:00 PM
To: FDADockets@oc.fda.gov
Cc: JD Bernardy
Subject: RE: Participation in Public Hearing on Combination Products
Containing Live Cellular Components

Ladies and Gentlemen,

	Please disregard our earlier correspondence (below) as I will be unable to
attend the June 24 2002 public hearing on combination products containing
live cellular components.  We will plan to submit our comments in writtent
form.

	Sincerely,

	David Dove, M.D.

David Dove, M.D.
President & CEO
Celadon Science Inc.
59 Evans Road
Brookline MA 02445
Tel. 617.566.8449
Fax 413.723.5661
Cell 917.741.2852
Email: daviddove1@rcn.com


-----Original Message-----
From: jd.bernardy@praecis.com [mailto:jd.bernardy@praecis.com]
Sent: Friday, June 14, 2002 10:58 AM
To: FDADockets@oc.fda.gov
Cc: daviddove1@rcn.com
Subject: Participation in Public Hearing on Combination Products
Containing Live Cellular Components


Ladies and Gentlemen,

     Please register Dr David Dove as a particpant in the 24 June 2002
public hearing on combination products containing live cellular components.
     His address and phone numbers are:
               David Dove, M.D.
               President & CEO
               Celadon Science Inc.
               59 Evans Road
               Brookline MA 02445
               Tel. 617.566.8449
               Fax 413.723.5661
               Cell 917.741.2852
               Email: daviddove1@rcn.com

          Sincerely,
          J D Bernardy, JD
          Regulatory Consultant
          Ph:781-795-4282